The molecular basis of the type 1 glycogen storage diseases.
Microsomal glucose-6-phosphatase catalyses the last step in liver glucose production. Glucose-6-phosphatase deficiency, now termed type 1 glycogen storage disease, was first described almost 40 years ago but until recently very little was known about the molecular basis of the various type 1 glycogen storage diseases. Recently we have shown that at least six different proteins are needed for normal glucose-6-phosphatase activity in liver. Four of the proteins have been purified and three cloned. Study of the type 1 glycogen storage diseases has stimulated investigations of the mechanisms of small molecule transport across the endoplasmic reticulum membrane and demonstrated the existence of novel endoplasmic reticulum transport proteins for glucose and phosphate.
Burchell
A
A
Department of Obstetrics and Gynaecology, University of Dundee, Ninewells Hospital and Medical School, Scotland, UK.
D000818:Animals; D001692:Biological Transport; D015342:DNA Probes; D005953:Glycogen Storage Disease Type I / Q000378:metabolism*; D006801:Humans; D008861:Microsomes / Q000378:metabolism; D008954:Models, Biological; D010710:Phosphates / Q000378:metabolism
D015342:DNA Probes; D010710:Phosphates